
  
    
      
        Background_NNP
        There_EX are_VBP three_CD general_JJ mechanisms_NNS whereby_WRB vascular_NN
        smooth_JJ muscle_NN force_NN is_VBZ regulated_VBN ._. 1_LS )_) Activation_NNP mechanisms_NNS
        involve_VBP contractile_NN pathways_NNS that_WDT increase_NN ser_NN 19_CD -_: myosin_NN
        regulatory_JJ light_JJ chain_NN (_( MRLC_NNP )_) phosphorylation_NN ,_, either_CC by_IN
        increases_NNS in_IN myoplasmic_JJ calcium_NN (_( [_NN Ca_MD 2_CD +_NN ]_NN 
        i_NNP [_NN 1_CD ]_NN )_) or_CC by_IN decreases_NNS in_IN myosin_NN
        light_JJ chain_NN phosphatase_NN activity_NN [_NN 2_CD ]_NN ._. The_DT increased_VBN ser_NN
        19_CD -_: MRLC_NNP phosphorylation_NN activates_NNS the_DT myosin_NN 's_POS ATPase_NNP
        producing_VBG crossbridge_NN cycling_NN and_CC contraction_NN ._. 2_LS )_)
        Deactivation_NNP mechanisms_NNS are_VBP the_DT reversal_NN of_IN activation_NN
        mechanisms_NNS :_: relaxation_NN results_NNS from_IN lower_JJR ser_NN 19_CD -_: MRLC_NNP
        phosphorylation_NN induced_VBN by_IN either_DT reductions_NNS in_IN [_NN Ca_MD 2_CD +_NN ]_NN [_NN 3_CD
        4_CD ]_NN or_CC increases_NNS in_IN myosin_NN light_JJ chain_NN phosphatase_NN activity_NN
        [_NN 5_CD ]_NN ._. Since_IN dephosphoylated_JJ myosin_NN does_VBZ not_RB cycle_NN ,_, force_NN
        is_VBZ reduced_VBN ._. 3_LS )_) Force_NNP suppression_NN occurs_VBZ when_WRB force_NN is_VBZ
        reduced_VBN despite_IN persistent_JJ elevation_NN in_IN ser_NN 19_CD -_: MRLC_NNP
        phosphorylation_NN levels_NNS ._. This_DT is_VBZ an_DT exception_NN to_TO the_DT above_JJ
        MRLC_NNP phosphorylation_NN paradigm_NN since_IN phosphorylated_JJ myosin_NN
        should_MD cycle_NN and_CC produce_VB force_NN ._. Force_NNP suppression_NN has_VBZ been_VBN
        observed_VBN with_IN elevations_NNS in_IN [_NN cGMP_NN ]_NN [_NN 6_CD 7_CD ]_NN ,_, [_NN cAMP_NN ]_NN [_NN 8_CD ]_NN ,_,
        extracellular_NN [_NN Mg_NNP 2_CD +_NN ]_NN [_NN 9_CD ]_NN ,_, and_CC with_IN some_DT pharmacologic_JJ
        treatments_NNS ._.
        Cyclic_NNP nucleotide_NN induced_VBD relaxation_NN is_VBZ associated_VBN with_IN
        phosphorylation_NN of_IN heat_NN shock_NN protein_NN 20_CD (_( also_RB known_VBN as_IN
        HSP_NNP 20_CD or_CC P_NN 20_CD )_) on_IN serine_NN 16_CD [_NN 10_CD 11_CD 12_CD ]_NN ._. More_RBR recently_RB ,_,
        ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN was_VBD shown_VBN to_TO specifically_RB and_CC
        temporally_RB correlate_VBP with_IN "_'' force_NN suppression_NN "_'' rather_RB than_IN
        the_DT "_'' deactivation_NN "_'' form_NN of_IN relaxation_NN [_NN 8_CD 10_CD ]_NN ._. A_DT region_NN
        of_IN HSP_NNP 20_CD (_( residues_NNS 110_CD -_: 121_CD )_) has_VBZ sequence_NN homology_NN with_IN
        troponin_NN I_PRP ;_: peptides_NNS from_IN this_DT region_NN bound_VBN thin_JJ filaments_NNS ,_,
        reduced_VBN actin_NN activated_VBN myosin_NN S_NNP 1_CD ATPase_NNP activity_NN ,_, and_CC
        relaxed_VBD skinned_JJ swine_NNS carotid_NN artery_NN [_NN 10_CD ]_NN ._. We_PRP
        hypothesized_VBN that_IN binding_JJ of_IN ser_NN 16_CD -_: phosphorylated_JJ HSP_NNP 20_CD to_TO
        the_DT thin_JJ filament_NN may_MD "_'' turn_VB off_RP "_'' thin_JJ filaments_NNS so_IN that_IN
        phosphorylated_JJ myosin_NN does_VBZ not_RB interact_NN with_IN the_DT thin_JJ
        filament_NN (_( i_NNP ._. e_SYM ._. a_DT model_NN similar_JJ to_TO skeletal_NN muscle_NN troponin_NN
        I_PRP )_) ._. This_DT would_MD explain_VB low_JJ force_NN with_IN elevated_VBD MRLC_NNP
        phosphorylation_NN ._. HSP_NNP 20_CD has_VBZ a_DT second_JJ phosphorylation_NN site_NN ,_,
        presumptively_RB phosphorylated_JJ by_IN PKC_NNP [_NN 12_CD ]_NN ,_, of_IN unclear_JJ
        significance_NN ._.
        HSP_NNP 20_CD is_VBZ a_DT member_NN of_IN the_DT heat_NN shock_NN protein_NN superfamily_RB
        and_CC is_VBZ known_VBN to_TO provide_VB resistance_NN to_TO heat_VB treatment_NN in_IN
        cells_NNS [_NN 13_CD ]_NN ._. Recently_RB we_PRP found_VBD that_DT heat_NN pretreatment_NN (_( 4_CD
        hours_NNS at_IN 44_CD ._. 5_LS °_NN C_NNP )_) of_IN swine_NNS carotid_NN artery_NN increased_VBD ser_NN
        16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC suppressed_VBN force_NN [_NN 14_CD ]_NN ._. In_IN
        this_DT study_NN ,_, we_PRP addressed_VBD three_CD questions_NNS :_: 1_LS )_) What_WP is_VBZ the_DT
        temperature_NN threshold_NN for_IN increases_NNS in_IN ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN and_CC force_NN suppression_NN ?_. 2_LS )_) Does_VBZ the_DT heat_NN
        pretreatment_NN response_NN diminish_VB by_IN prolonged_JJ recovery_NN at_IN
        37_CD °_NN C_NNP after_IN heat_NN treatment_NN ,_, i_NNP ._. e_SYM ._. is_VBZ the_DT heat_NN pretreatment_NN
        reversible_JJ ?_. And_CC 3_LS )_) Are_VBP increases_NNS in_IN [_NN cAMP_NN ]_NN or_CC [_NN cGMP_NN ]_NN
        responsible_JJ for_IN the_DT heat-induced_JJ increases_NNS in_IN ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN ?_.
      
      
        Results_NNS
        
          Experimental_NNP protocol_NN
          Tissues_NNPS were_VBD first_JJ equilibrated_JJ at_IN 37_CD °_NN C_NNP [_NN 15_CD ]_NN ._. This_DT
          involved_VBD a_DT "_'' warm-up_NN "_'' 109_CD mM_NN K_NNP +_NN contraction_NN approximately_RB
          30_CD min_NN after_IN mounting_VBG ,_, repeated_VBN stretching_VBG to_TO ~_NN 1_CD ×_NN 10_CD
          5_CD N_NNP /_NN m_NN 2_CD (_( ~_NN 20_CD g_SYM for_IN a_DT 20_CD mg_NN tissue_NN )_) ,_, a_DT release_NN to_TO ~_NN 0_CD ._. 2_LS ×_NN 10_CD
          5_CD N_NNP /_NN m_NN 2_CD (_( ~_NN 4_CD g_SYM )_) ,_, and_CC a_DT second_JJ 109_CD mM_NN K_NNP +_NN contraction_NN
          approximately_RB 120_CD min_NN after_IN mounting_VBG ._. This_DT protocol_NN sets_VBZ
          the_DT muscle_NN to_TO the_DT optimal_NN length_NN for_IN force_NN generation_NN ._.
          The_DT latter_JJ K_NNP +_NN contraction_NN was_VBD used_VBN for_IN force_NN
          normalization_NN ._. Tissues_NNPS were_VBD then_RB exposed_VBN to_TO various_JJ
          temperatures_NNS for_IN various_JJ times_NNS (_( solutions_NNS were_VBD replaced_VBN
          if_IN evaporation_NN was_VBD observed_VBN )_) ._. Temperature_NNP was_VBD changed_VBN by_IN
          adjusting_VBG the_DT water_NN bath_NN set_VBD point_NN ._. This_DT procedure_NN
          increased_VBN temperature_NN within_IN 5_CD min_NN ._. Reducing_VBG temperature_NN
          would_MD have_VB been_VBN slower_JJR but_CC was_VBD accelerated_VBN by_IN adding_VBG ice_NN
          to_TO the_DT water_NN bath_NN ._. After_IN the_DT exposure_NN to_TO different_JJ
          temperatures_NNS ,_, tissues_NNS were_VBD returned_VBN to_TO 37_CD °_NN C_NNP for_IN various_JJ
          times_NNS ,_, contracted_VBD with_IN 10_CD μM_NN histamine_NN for_IN 10_CD min_NN ,_, and_CC
          then_RB frozen_VBN for_IN analysis_NN ._.
        
        
          Threshold_NNP for_IN temperature_NN dependent_JJ increase_NN in_IN ser_NN
          16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC force_NN suppression_NN
          Equilibrated_NNP swine_NNS carotid_NN medial_NN rings_NNS were_VBD exposed_VBN
          to_TO various_JJ temperatures_NNS for_IN 4_CD hours_NNS ,_, returned_VBD to_TO 37_CD °_NN C_NNP for_IN
          1_CD hour_NN ,_, contracted_VBD with_IN 10_CD μM_NN histamine_NN for_IN 10_CD min_NN ,_, and_CC
          then_RB frozen_VBN ._. Significant_JJ reduction_NN in_IN force_NN and_CC increases_NNS
          in_IN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN were_VBD observed_VBN with_IN heat_NN
          treatments_NNS between_IN 43_CD °_NN C_NNP and_CC 46_CD °_NN C_NNP (_( Fig_NNP ._. 1_LS )_) ._. Ser_NNP 19_CD -_: MRLC_NNP
          phosphorylation_NN levels_NNS did_VBD not_RB significantly_RB differ_VB in_IN
          tissues_NNS treated_VBN at_IN 44_CD ._. 5_LS °_NN C_NNP or_CC 37_CD °_NN C_NNP ,_, suggesting_VBG that_IN the_DT
          decreased_VBN force_NN observed_VBD at_IN 44_CD ._. 5_LS °_NN C_NNP was_VBD force_NN
          suppression_NN ._.
          Histamine_NNP did_VBD not_RB induce_VB any_DT contraction_NN after_IN
          pretreatment_NN at_IN 47_CD ._. 5_LS °_NN C_NNP ,_, and_CC histamine_NN also_RB did_VBD not_RB
          significantly_RB increase_VB ser_NN 19_CD -_: MRLC_NNP phosphorylation_NN levels_NNS
          (_( MRLC_NNP phosphorylation_NN was_VBD significantly_RB less_JJR than_IN that_DT
          observed_VBD at_IN 37_CD °_NN C_NNP )_) ._. This_DT result_NN suggests_VBZ that_IN the_DT
          decreased_VBN force_NN observed_VBD at_IN 47_CD ._. 5_LS °_NN C_NNP was_VBD caused_VBN by_IN reduced_VBN
          ser_NN 19_CD -_: MRLC_NNP phosphorylation_NN ._. Ser_NNP 16_CD -_: HSP_NNP 20_CD phosphorylation_NN
          at_IN 47_CD ._. 5_LS °_NN C_NNP was_VBD significantly_RB lower_JJR than_IN that_DT observed_VBD at_IN
          44_CD ._. 5_LS °_NN C_NNP but_CC higher_JJR than_IN that_DT observed_VBD at_IN 37_CD °_NN C_NNP ._. These_DT data_NNS
          suggest_VBP a_DT biphasic_JJ response_NN with_IN ser_NN 16_CD -_: HSP_NNP 20_CD
          phosphorylation-associated_JJ force_NN suppression_NN with_IN heat_NN
          pretreatment_NN between_IN 43_CD and_CC 46_CD °_NN C_NNP and_CC deactivation_NN by_IN
          inhibition_NN of_IN ser_NN 19_CD -_: MRLC_NNP phosphorylation_NN after_IN heat_NN
          pretreatment_NN at_IN 47_CD ._. 5_LS °_NN C_NNP ._.
          Pretreatment_NNP at_IN 2_CD °_NN C_NNP induced_VBD a_DT small_JJ ,_, insignificant_JJ
          increase_NN in_IN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN without_IN
          significant_JJ effects_NNS on_IN force_NN ._. Putative_NNP PKC-HSP_NNP 20_CD
          phosphorylation_NN [_NN 12_CD ]_NN was_VBD not_RB significantly_RB altered_VBN at_IN
          any_DT tested_VBN temperature_NN ._.
        
        
          Recovery_NNP after_IN heat_NN treatment_NN
          Swine_NNP carotid_NN medial_NN rings_NNS were_VBD exposed_VBN to_TO 44_CD ._. 5_LS °_NN C_NNP for_IN
          4_CD hours_NNS ,_, followed_VBN by_IN 37_CD °_NN C_NNP for_IN various_JJ times_NNS before_IN
          stimulation_NN with_IN 10_CD μM_NN histamine_NN for_IN 10_CD min_NN and_CC freezing_NN
          (_( Fig_NNP ._. 2_LS )_) ._. A_DT set_NN of_IN control_NN tissues_NNS were_VBD not_RB exposed_VBN to_TO
          44_CD ._. 5_LS °_NN C_NNP and_CC had_VBD low_JJ ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN (_( labeled_VBN
          "_'' before_IN "_'' )_) ._. Ser_NNP 16_CD -_: HSP_NNP 20_CD phosphorylation_NN levels_NNS were_VBD high_JJ
          both_DT in_IN tissues_NNS that_WDT were_VBD histamine_NN stimulated_VBN at_IN 44_CD ._. 5_LS °_NN C_NNP
          (_( 0_CD time_NN ,_, i_NNP ._. e_SYM ._. no_DT recovery_NN at_IN 37_CD °_NN C_NNP )_) and_CC in_IN tissues_NNS that_WDT
          were_VBD returned_VBN to_TO 37_CD °_NN C_NNP for_IN 15_CD min_NN to_TO 16_CD hours_NNS ._. Force_NNP was_VBD
          suppressed_VBN in_IN all_DT heat-treated_JJ tissues_NNS regardless_RB of_IN
          recovery_NN time_NN ._. There_EX appeared_VBD to_TO be_VB a_DT modest_JJ rebound_NN in_IN
          histamine-induced_JJ contraction_NN 1_CD to_TO 8_CD hours_NNS after_IN return_NN
          to_TO 37_CD °_NN C_NNP ._.
        
        
          Dependence_NNP of_IN histamine-induced_JJ force_NN on_IN ser_NN
          16_CD -_: HSP_NNP 20_CD phosphorylation_NN
          The_DT relation_NN between_IN mean_NN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN
          and_CC mean_VB force_NN from_IN all_PDT the_DT tissues_NNS that_WDT were_VBD stimulated_VBN
          with_IN histamine_NN is_VBZ shown_VBN in_IN the_DT upper_JJ panel_NN of_IN Fig_NNP ._. 3_LS ._.
          There_EX is_VBZ a_DT clear_JJ relation_NN between_IN reduced_VBN
          histamine-induced_JJ force_NN and_CC increased_VBN ser_NN 16_CD -_: HSP_NNP 20_CD
          phosphorylation_NN with_IN all_DT treatments_NNS except_IN the_DT 47_CD ._. 5_LS °_NN C_NNP
          heat_NN pretreatment_NN protocol_NN ._. The_DT lack_NN of_IN correlation_NN at_IN
          47_CD ._. 5_LS °_NN C_NNP is_VBZ expected_VBN given_VBN the_DT lower_JJR ser_NN 19_CD -_: MRLC_NNP
          phosphorylation_NN (_( i_NNP ._. e_SYM ._. deactivation_NN )_) observed_VBD after_IN 47_CD ._. 5_LS °_NN C_NNP
          pretreatment_NN ._. There_EX was_VBD no_DT correlation_NN between_IN putative_JJ
          PKC-HSP_NNP 20_CD phosphorylation_NN and_CC force_NN (_( lower_JJR panel_NN of_IN Fig_NNP ._.
          3_LS )_) ._.
        
        
          Cyclic_NNP nucleotide_NN levels_NNS did_VBD not_RB correlate_VBP with_IN
          heat_NN induced_VBD ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN levels_NNS
          Swine_NNP carotid_NN medial_NN rings_NNS were_VBD stimulated_VBN with_IN 10_CD μM_NN
          histamine_NN for_IN 10_CD min_NN either_CC before_IN (_( control_NN )_) or_CC at_IN the_DT
          end_NN of_IN a_DT 4_CD hour_NN 44_CD ._. 5_LS °_NN C_NNP treatment_NN ._. Heat_NNP pretreatment_NN did_VBD
          not_RB significantly_RB alter_VB [_NN cAMP_NN ]_NN and_CC [_NN cGMP_NN ]_NN levels_NNS despite_IN
          significantly_RB increased_VBN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC
          suppressed_VBN force_NN ._. These_DT data_NNS suggest_VBP that_IN the_DT increases_NNS
          in_IN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN cannot_NN be_VB explained_VBN by_IN
          elevated_JJ [_NN cAMP_NN ]_NN and_CC [_NN cGMP_NN ]_NN levels_NNS after_IN 4_CD hours_NNS of_IN heat_NN
          pretreatment_NN ._.
        
      
      
        Discussion_NNP
        Our_PRP$ prior_RB study_NN [_NN 14_CD ]_NN found_VBD that_IN 1_LS )_) 44_CD ._. 5_LS °_NN C_NNP heat_NN
        pretreatment_NN of_IN swine_NNS carotid_NN artery_NN increased_VBD ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN and_CC suppressed_VBN force_NN ,_, i_NNP ._. e_SYM ._. ,_, a_DT reduction_NN in_IN
        force_NN without_IN a_DT significant_JJ reduction_NN in_IN MRLC_NNP
        phosphorylation_NN ._. 2_LS )_) The_DT effects_NNS of_IN heat_NN pretreatment_NN and_CC
        nitroglycerin_NN were_VBD additive_JJ ,_, both_DT on_IN increasing_VBG ser_NN
        16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC suppressing_VBG force_NN [_NN 14_CD ]_NN ._. And_CC
        3_LS )_) the_DT relation_NN between_IN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC
        force_NN was_VBD similar_JJ with_IN heat_NN pretreatment_NN and_CC nitroglycerin_NN ,_,
        suggesting_VBG a_DT similar_JJ mechanism_NN of_IN action_NN to_TO suppress_VB force_NN
        [_NN 14_CD ]_NN ._.
        The_DT goal_NN of_IN this_DT study_NN was_VBD to_TO extend_VB our_PRP$ observations_NNS on_IN
        heat_NN treatment_NN ._. We_PRP found_VBD that_IN temperatures_NNS between_IN 43_CD and_CC
        46_CD °_NN C_NNP increased_VBD ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC suppressed_VBN
        force_NN ,_, i_NNP ._. e_SYM ._. reduced_VBN force_NN without_IN reductions_NNS in_IN ser_NN 19_CD -_: MRLC_NNP
        phosphorylation_NN (_( Fig_NNP ._. 1_LS )_) ._. Excepting_NNP the_DT 47_CD ._. 5_LS °_NN C_NNP response_NN ,_,
        the_DT relation_NN between_IN mean_NN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC
        mean_VB force_NN was_VBD similar_JJ with_IN all_DT treatments_NNS in_IN these_DT
        histamine_NN stimulated_VBN tissues_NNS (_( top_JJ panel_NN ,_, Fig_NNP ._. 3_LS )_) ,_,
        consistent_JJ with_IN the_DT hypothesis_NNS that_WDT ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN was_VBD mediating_VBG force_NN suppression_NN ._.
        No_DT contraction_NN was_VBD observed_VBN after_IN pretreatment_NN at_IN
        47_CD ._. 5_LS °_NN C_NNP ,_, however_RB ,_, this_DT was_VBD not_RB force_VB suppression_NN since_IN MRLC_NNP
        phosphorylation_NN was_VBD significantly_RB reduced_VBN to_TO near_IN basal_NN
        levels_NNS for_IN the_DT swine_NNS carotid_NN ._. This_DT may_MD explain_VB why_WRB the_DT
        response_NN observed_VBD after_IN 47_CD ._. 5_LS °_NN C_NNP was_VBD not_RB on_IN the_DT ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN /_NN force_NN relation_NN shown_VBN in_IN Fig_NNP ._. 3_LS ._. This_DT
        finding_VBG is_VBZ consistent_JJ with_IN the_DT hypothesis_NNS that_IN different_JJ
        temperatures_NNS reduce_VBP force_NN by_IN different_JJ mechanisms_NNS ._. For_IN
        example_NN ,_, whole_JJ body_NN hyperthermia_NN at_IN 41_CD ._. 5_LS °_NN C_NNP induced_VBD
        apoptosis_NNS in_IN rats_NNS [_NN 16_CD ]_NN while_IN exposure_NN to_TO 48_CD °_NN C_NNP reportedly_RB
        induces_VBZ necrosis_NNS in_IN cultured_JJ cells_NNS [_NN 17_CD ]_NN ._. The_DT similar_JJ
        temperature_NN sensitivity_NN of_IN apoptosis_NNS and_CC ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN suggests_VBZ the_DT possibility_NN of_IN a_DT role_NN for_IN
        HSP_NNP 20_CD in_IN the_DT promotion_NN of_IN or_CC protection_NN from_IN apoptosis_NNS ._. It_PRP
        is_VBZ possible_JJ that_IN HSP_NNP 20_CD induced_VBN force_NN suppression_NN may_MD be_VB
        part_NN of_IN a_DT protective_JJ response_NN to_TO moderate_VB heat_NN exposure_NN ._. In_IN
        contrast_NN ,_, the_DT absence_NN of_IN a_DT contractile_NN and_CC MRLC_NNP
        phosphorylation_NN response_NN after_IN more_JJR extreme_JJ heat_NN exposure_NN
        (_( 47_CD ._. 5_LS °_NN C_NNP )_) may_MD represent_VB tissue_NN necrosis_NNS ._.
        There_EX was_VBD no_DT significant_JJ change_NN in_IN putative_JJ PKC-HSP_NNP 20_CD
        phosphorylation_NN [_NN 12_CD ]_NN with_IN any_DT protocol_NN ._. As_IN a_DT result_NN there_EX
        was_VBD no_DT correlation_NN between_IN putative_JJ PKC-HSP_NNP 20_CD
        phosphorylation_NN and_CC force_NN (_( lower_JJR panel_NN of_IN Fig_NNP ._. 3_LS )_) ._.
        We_PRP also_RB investigated_VBD whether_IN the_DT heat_NN pretreatment_NN
        response_NN was_VBD reversible_JJ ._. Ser_NNP 16_CD -_: HSP_NNP 20_CD phosphorylation_NN
        levels_NNS remained_VBD elevated_VBD and_CC overall_JJ force_NN remained_VBD low_JJ up_IN
        to_TO 16_CD hours_NNS after_IN return_NN of_IN heat_NN treated_VBD tissues_NNS to_TO 37_CD °_NN C_NNP ._.
        This_DT suggests_VBZ that_IN the_DT process_NN that_IN increases_NNS ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN is_VBZ not_RB reversible_JJ ,_, at_IN least_JJS in_IN vitro_NN ._. This_DT
        may_MD indicate_VB substantial_JJ tissue_NN damage_NN during_IN the_DT 4_CD hour_NN
        exposure_NN at_IN 44_CD ._. 5_LS °_NN C_NNP ._.
        Finally_RB ,_, we_PRP found_VBD that_IN the_DT increases_NNS in_IN ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN were_VBD not_RB explained_VBN by_IN increases_NNS in_IN [_NN cAMP_NN ]_NN
        or_CC [_NN cGMP_NN ]_NN at_IN the_DT end_NN of_IN heat_NN treatment_NN (_( Fig_NNP ._. 4_LS )_) ._. This_DT
        suggests_VBZ that_IN some_DT other_JJ mechanism_NN keeps_VBZ ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN at_IN high_JJ levels_NNS ._. Considering_VBG that_IN the_DT
        increased_VBN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN remains_VBZ elevated_VBD for_IN
        16_CD hours_NNS after_IN return_NN to_TO 37_CD °_NN C_NNP ,_, it_PRP is_VBZ possible_JJ that_DT heat_NN
        treatment_NN is_VBZ reducing_VBG HSP_NNP 20_CD phosphatase_NN activity_NN ._.
        Our_PRP$ experiments_NNS suggest_VBP that_IN temperatures_NNS of_IN 43_CD °_NN C_NNP and_CC
        above_IN can_MD alter_VB arterial_NN contractility_NN ._. Such_JJ temperatures_NNS
        can_MD occur_VB physiologically_RB ._. Brooks_NNP ,_, et_CC ._. al_NN ._. [_NN 18_CD ]_NN
        exhaustively_RB exercised_VBD rats_NNS for_IN 90_CD min_NN on_IN treadmills_NNS ._.
        Immediately_RB after_IN exercise_NN (_( not_RB during_IN )_) ,_, thermocouples_NNS were_VBD
        inserted_VBN into_IN thigh_NN skeletal_NN muscles_NNS and_CC the_DT rectum_NN ._. They_PRP
        found_VBD an_DT initial_JJ mean_NN temperature_NN of_IN 44_CD ._. 1_LS °_NN C_NNP in_IN skeletal_NN
        muscle_NN and_CC 42_CD ._. 1_LS °_NN C_NNP rectally_RB ._. Both_DT temperatures_NNS fell_VBD
        exponentially_RB with_IN rest_NN after_IN exercise_NN ._. It_PRP is_VBZ likely_JJ that_DT
        muscle_NN temperature_NN exceeded_VBD 44_CD ._. 1_LS °_NN C_NNP for_IN at_IN least_JJS part_NN of_IN the_DT
        90_CD min_NN exercise_NN ._. This_DT suggests_VBZ that_IN profound_JJ exercise_NN can_MD
        increase_VB regional_JJ temperature_NN to_TO levels_NNS that_WDT could_MD
        potentially_RB induce_VB ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC force_NN
        suppression_NN ._. Thermal_JJ stress_NN may_MD bring_VB about_IN a_DT resistance_NN to_TO
        contractile_NN agonists_NNS ,_, which_WDT could_MD have_VB clinical_JJ
        significance_NN in_IN conditions_NNS such_JJ as_IN hyperthermia_NN ,_, and_CC /_NN or_CC
        sepsis_NN with_IN vasodilatory_NN shock_NN ._.
        Heat_NNP treatment_NN may_MD have_VB effects_NNS on_IN smooth_JJ muscle_NN beyond_IN
        contractility_NN ._. Orihara_NNP et_CC al_NN ._. [_NN 19_CD ]_NN reported_VBD that_DT exposure_NN
        of_IN vascular_NN smooth_JJ muscle_NN cells_NNS to_TO 43_CD °_NN C_NNP for_IN 2_CD hours_NNS
        inhibited_VBD cell_NN proliferation_NN ._. Further_RB work_NN is_VBZ required_VBN to_TO
        assess_VB whether_IN HSP_NNP 20_CD is_VBZ involved_VBN in_IN this_DT response_NN ._.
        These_DT results_NNS also_RB demonstrate_VBP that_IN multiple_JJ mechanisms_NNS
        can_MD induce_VB force_NN suppression_NN that_WDT is_VBZ correlated_JJ with_IN ser_NN
        16_CD -_: HSP_NNP 20_CD phosphorylation_NN ._. Our_PRP$ prior_RB studies_VBZ showed_VBD that_IN
        increases_NNS in_IN cGMP_NN by_IN nitrovasodilators_NNS and_CC cAMP_NN by_IN
        forskolin_NN increase_NN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC induce_VB
        force_NN suppression_NN [_NN 8_CD ]_NN ._. Such_JJ results_NNS suggest_VBP that_IN the_DT
        correlation_NN between_IN ser_NN 16_CD -_: HSP_NNP 20_CD phosphorylation_NN and_CC force_NN
        suppression_NN is_VBZ robust_JJ in_IN the_DT swine_NNS carotid_NN stimulated_VBN with_IN
        10_CD μM_NN histamine_NN ._. However_RB ,_, it_PRP must_MD be_VB stressed_VBN that_IN
        different_JJ contractile_NN conditions_NNS may_MD be_VB associated_VBN with_IN
        different_JJ relationships_NNS between_IN ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN and_CC force_NN given_VBN the_DT multiple_JJ mechanisms_NNS
        whereby_WRB agents_NNS can_MD cause_VB relaxation_NN [_NN 3_CD 4_CD 5_CD ]_NN ._. For_IN
        example_NN ,_, smooth_JJ muscle_NN relaxation_NN can_MD occur_VB by_IN agents_NNS that_WDT
        reduce_VBP myoplasmic_JJ Ca_MD 2_CD +_NN by_IN inducing_VBG hyperpolarization_NN ,_,
        reducing_VBG Ca_MD 2_CD +_NN influx_NN without_IN changes_NNS in_IN membrane_NN potential_JJ ,_,
        increasing_VBG Ca_MD 2_CD +_NN efflux_NN ,_, or_CC by_IN reducing_VBG Ca_MD 2_CD +_NN release_NN from_IN
        the_DT internal_JJ store_NN ._. The_DT response_NN can_MD depend_VB on_IN the_DT form_NN of_IN
        contractile_NN activation_NN ,_, e_SYM ._. g_SYM ._. nitroglycerin_NN reduces_VBZ Ca_MD
        2_CD +_NN better_JJR after_IN agonist_NN activation_NN compared_VBN with_IN K_NNP
        +_NN depolarization_NN [_NN 20_CD ]_NN ._. Comparison_NNP of_IN ser_NN 16_CD -_: HSP_NNP 20_CD
        phosphorylation_NN /_NN force_NN relationships_NNS require_VBP careful_JJ
        analysis_NN in_IN comparison_NN with_IN ser_NN 19_CD -_: MRLC_NNP phosphorylation_NN
        levels_NNS to_TO clearly_RB show_VB that_IN the_DT change_NN in_IN force_NN is_VBZ force_NN
        suppression_NN rather_RB than_IN deactivation_NN ._.
      
      
        Methods_NNP
        
          Tissues_NNPS
          Swine_NNP common_JJ carotid_NN arteries_NNS were_VBD obtained_VBN from_IN a_DT
          slaughterhouse_NN and_CC transported_VBN at_IN 0_CD °_NN C_NNP in_IN physiological_JJ
          salt_NN solution_NN (_( PSS_NNP )_) ._. PSS_NNP contained_VBD (_( mM_NN )_) :_: NaCl_NNP ,_, 140_CD ;_: KCl_NNP ,_,
          4_CD ._. 7_CD ;_: 3_CD -_: [_NN N-_NNP morpholino_NN ]_NN propane_NN sulfonic_JJ acid_NN (_( MOPS_NNP )_) 5_CD ;_: Na_NNP 
          2_CD HPO_NNP 
          4_CD ,_, 1_CD ._. 2_CD ;_: CaCl_NNP 
          2_CD ,_, 1_CD ._. 6_CD ;_: MgSO_NNP 
          4_CD ,_, 1_CD ._. 2_CD ;_: D-_NNP glucose_NN ,_, 5_CD ._. 6_CD ;_: pH_NN adjusted_VBN
          to_TO 7_CD ._. 4_CD at_IN 37_CD °_NN C_NNP ._. Dissection_NNP of_IN medial_NN rings_NNS ,_, mounting_VBG and_CC
          determination_NN of_IN the_DT optimum_JJ length_NN for_IN stress_NN
          development_NN at_IN 37_CD °_NN C_NNP was_VBD performed_VBN as_IN described_VBN [_NN 21_CD ]_NN ._.
          The_DT carotid_NN "_'' ring_NN "_'' preparation_NN differs_VBZ in_IN the_DT method_NN of_IN
          mounting_VBG from_IN our_PRP$ prior_RB heat_NN study_NN which_WDT employed_VBN carotid_NN
          "_'' strips_NNS "_'' [_NN 14_CD ]_NN ._. The_DT mounting_VBG procedure_NN ,_, rings_NNS vs_NNS ._.
          strips_NNS does_VBZ not_RB alter_VB the_DT behavior_NN of_IN the_DT carotid_NN media_NNS
          in_IN tissue_NN baths_NNS ._. The_DT intimal_NN surface_NN was_VBD mechanically_RB
          rubbed_VBD to_TO remove_VB the_DT endothelium_NN ._.
        
        
          Antibodies_NNP
          Rabbit_NNP anti-_NN HSP_NNP 20_CD antibody_NN was_VBD made_VBN commercially_RB via_IN
          repeated_VBN injection_NN of_IN gel_NN purified_JJ recombinant_JJ HSP_NNP 20_CD
          (_( sequence_NN confirmed_VBN by_IN mass_NN spectroscopy_NN )_) ._. After_IN
          confirmation_NN of_IN an_DT antigenic_JJ response_NN ,_, serum_NN was_VBD
          collected_VBN and_CC frozen_VBN for_IN future_JJ use_NN ._. Specificity_NNP was_VBD
          verified_VBN as_IN described_VBN [_NN 8_CD ]_NN ._.
        
        
          Measurement_NNP of_IN HSP_NNP 20_CD and_CC MRLC_NNP
          phosphorylation_NN
          Swine_NNP carotid_NN arteries_NNS were_VBD first_JJ thermally_RB and_CC
          histamine_NN stimulated_VBN ,_, followed_VBN by_IN freezing_NN in_IN an_DT
          acetone-dry_JJ ice_NN slurry_NN [_NN 15_CD ]_NN ._. After_IN air_NN drying_VBG ,_, the_DT
          tissues_NNS were_VBD homogenized_JJ in_IN a_DT buffer_NN (_( 20_CD mg_NN wet_JJ weight_NN
          tissue_NN /_NN ml_NN buffer_NN )_) containing_VBG 1_CD %_NN SDS_NNP ,_, 10_CD %_NN glycerol_NN ,_, and_CC 1_CD
          mM_NN dithiothreitol_NN ._. Full_NNP strength_NN ,_, half_JJ strength_NN ,_, and_CC
          quarter_NN strength_NN dilutions_NNS of_IN samples_NNS were_VBD then_RB separated_JJ
          on_IN one-dimensional_JJ isoelectric_JJ focusing_VBG gels_NNS (_( ampholytes_NNS
          were_VBD a_DT 50_CD :_: 50_CD mixture_NN of_IN pI_NN 4_CD -_: 6_CD ._. 5_LS and_CC pI_NN 5_CD -_: 8_CD for_IN HSP_NNP 20_CD and_CC
          a_DT 50_CD :_: 50_CD mixture_NN of_IN pI_NN 4_CD -_: 6_CD ._. 5_LS and_CC pI_NN 4_CD ._. 5_CD -_: 5_CD ._. 4_LS for_IN MRLC_NNP )_) ,_,
          blotted_JJ to_TO PVDF_NNP or_CC nitrocellulose_NN membranes_NNS ,_,
          immunostained_JJ with_IN our_PRP$ rabbit_NN polyclonal_NN anti-_NN HSP_NNP 20_CD
          antibody_NN (_( 1_CD :_: 5000_CD )_) or_CC rabbit_NN polyclonal_NN anti-_NN MRLC_NNP antibody_NN
          (_( 1_CD :_: 4000_CD in_IN 1_CD %_NN bovine_JJ serum_NN albumin_NN and_CC 0_CD ._. 01_CD %_NN sodium_NN
          azide_NN )_) ,_, and_CC detected_VBD with_IN enhanced_JJ chemifluorescence_NN
          (_( ECF_NNP )_) for_IN HSP_NNP 20_CD and_CC enhanced_JJ chemiluminescence_NN (_( ECL_NNP )_) for_IN
          MRLC_NNP [_NN 22_CD ]_NN ._. A_DT representative_NN blot_NN is_VBZ shown_VBN in_IN Fig_NNP ._. 5_LS ._.
          The_DT dilutions_NNS ensured_JJ that_IN the_DT detection_NN system_NN was_VBD in_IN
          the_DT linear_JJ range_NN ._. Immunoblots_NNP were_VBD scanned_JJ on_IN a_DT Molecular_NNP
          Dynamics_NNP fluorimager_NN ._.
          Phosphorylation_NNP was_VBD determined_VBN by_IN change_NN in_IN the_DT
          isoelectric_JJ point_NN (_( pI_NN )_) for_IN each_DT phosphorylation_NN species_NNS ._.
          There_EX are_VBP two_CD HSP_NNP 20_CD phosphorylation_NN sites_NNS in_IN the_DT swine_NNS
          carotid_NN ,_, therefore_RB ,_, there_EX are_VBP four_CD immunoreactive_JJ
          species_NNS :_: unphosphorylated_JJ at_IN pI_NN 6_CD ._. 3_CD (_( top_JJ band_NN in_IN Fig_NNP ._. 5_LS )_) ,_,
          monophosphorylated_JJ on_IN a_DT putative_JJ protein_NN kinase_NN C_NNP (_( PKC_NNP )_)
          site_NN at_IN pI_NN 6_CD ._. 0_CD (_( second_JJ from_IN the_DT top_JJ band_NN in_IN Fig_NNP ._. 5_LS )_) ,_,
          monophosphorylated_JJ on_IN ser_NN 16_CD at_IN pI_NN 5_CD ._. 9_CD (_( second_JJ from_IN the_DT
          bottom_JJ band_NN in_IN Fig_NNP ._. 5_LS )_) ,_, and_CC diphosphorylated_JJ on_IN both_DT ser_NN
          16_CD and_CC the_DT putative_JJ PKC_NNP site_NN at_IN pI_NN 5_CD ._. 7_CD (_( bottom_JJ band_NN in_IN
          Fig_NNP ._. 5_LS )_) ._. Phosphorylation_NNP at_IN ser_NN 16_CD was_VBD confirmed_VBN by_IN mass_NN
          spectroscopy_NN sequencing_VBG of_IN the_DT pI_NN 5_CD ._. 7_CD isoform_NN in_IN our_PRP$
          laboratory_NN ._. Ser_NNP 16_CD -_: HSP_NNP 20_CD phosphorylation_NN was_VBD reported_VBN as_IN
          the_DT percent_NN of_IN ser_NN 16_CD monophosphorylated_JJ (_( pI_NN 5_CD ._. 9_CD )_) plus_CC
          diphosphorylated_JJ HSP_NNP 20_CD (_( pI_NN 5_CD ._. 7_CD )_) in_IN relation_NN to_TO the_DT sum_NN of_IN
          all_DT four_CD species_NNS ._.
          Identification_NNP of_IN the_DT "_'' PKC_NNP "_'' site_NN is_VBZ putative_JJ and_CC is_VBZ
          best_JJS described_VBN by_IN Beall_NNP ,_, et_CC al_NN ._. [_NN 12_CD ]_NN ._. They_PRP found_VBD that_DT
          phorbol_NN dibutyrate_NN induced_VBD phosphorylation_NN in_IN the_DT C_NNP
          terminal_NN region_NN of_IN HSP_NNP 20_CD based_VBN on_IN tryptic_JJ digest_VB
          analysis_NN ._. We_PRP calculated_VBD putative_JJ PKC-HSP_NNP 20_CD
          phosphorylation_NN as_IN the_DT percent_NN of_IN putative_JJ PKC_NNP
          monophosphorylated_JJ HSP_NNP 20_CD (_( pI_NN 6_CD ._. 0_CD )_) plus_CC diphosphorylated_JJ
          HSP_NNP 20_CD (_( pI_NN 5_CD ._. 7_CD )_) in_IN relation_NN to_TO the_DT sum_NN of_IN all_DT species_NNS ._. For_IN
          MRLC_NNP ,_, phosphorylation_NN was_VBD determined_VBN as_IN the_DT percent_NN of_IN
          phosphorylated_JJ smooth_JJ muscle_NN MRLC_NNP in_IN relation_NN to_TO total_VB
          smooth_JJ muscle_NN MRLC_NNP (_( i_NNP ._. e_SYM ._. non-muscle_JJ MRLC_NNP were_VBD
          ignored_VBN )_) ._.
        
        
          Cyclic_NNP nucleotide_NN assays_NNS
          [_NN cAMP_NN ]_NN and_CC [_NN cAMP_NN ]_NN were_VBD determined_VBN by_IN immunoassays_NNS were_VBD
          performed_VBN in_IN a_DT separate_JJ set_NN of_IN tissues_NNS treated_VBN
          identically_RB except_IN the_DT homogenization_NN buffer_NN was_VBD 0_CD ._. 1_CD M_NNP
          HCl_NNP (_( detailed_JJ methods_NNS in_IN [_NN 23_CD ]_NN )_) ._. Prior_RB analyses_NNS showed_VBD
          the_DT sensitivity_NN of_IN these_DT assays_NNS in_IN carotis_NNS smooth_JJ muscle_NN
          homogenates_NNS [_NN 23_CD ]_NN ._. The_DT University_NNP of_IN Virginia_NNP Diabetes_NNP
          Core_NNP lab_NN performed_VBD the_DT immunoassays_NNS with_IN commercial_JJ
          reagents_NNS ._.
        
        
          Statistics_NNS
          Data_NNP are_VBP presented_VBN in_IN the_DT text_NN and_CC figures_NNS as_IN mean_NN ±_NN 1_CD
          SEM_NNP ._. Symbols_NNP without_IN error_NN bars_NNS reflect_VBP errors_NNS smaller_JJR
          than_IN the_DT size_NN of_IN the_DT symbol_NN ._. Data_NNP were_VBD compared_VBN by_IN ANOVA_NNP
          and_CC Student-_NNP Newman-_NNP Keuls_NNP if_IN n_NN >_NN 2_CD and_CC Student_NNP 's_POS
          unpaired_JJ t_NN test_NN if_IN n_NN =_SYM 2_CD with_IN significance_NN defined_VBN as_IN p_NN
          <_NN 0_CD ._. 05_CD ._.
        
      
      
        Authors_NNP '_'' Contributions_NNP
        CR_NNP designed_VBD the_DT study_NN and_CC wrote_VBD the_DT manuscript_NN ._. EK_NNP
        performed_VBD the_DT experiments_NNS ._.
      
    
  
